Conference Day Two | Thursday, 26 June

8:00 am Check-In & Coffee

8:55 am Chair’s Opening Remarks

Implementing Strategic Initiatives & Defining Cross-Functional KPIs with Internal & External Stakeholders

9:00 am Navigating Scope 3: Improving Data Accuracy & Supplier Collaboration

  • Anna Weekes Supplier Decarbonization Manager, Thermo Fisher Scientific

Synopsis

  • Addressing challenges in collecting accurate data from direct suppliers and down the value chain
  • Providing suppliers with the tools and information to improve data collection accuracy, reduce emissions, and increase visibility through life cycle analysis and shared strategies
  • Exploring practical implementations for reducing Scope 3 emissions globally and quantifying and reporting supplier-driven changes effectively

9:30 am Driving ESG Change: Managing People, Processes, & Mindsets for Sustainable Success

  • Anica Bartolic Associate Director - People & Organizational Culture Development, Ergomed

Synopsis

  • Reiterating and communicating ESG goals effectively across functions to build a unified, cross-functional mindset
  • Addressing the workforce impact of additional ESG responsibilities on top of their workload
  • Transforming culture and mindset through internal initiatives that prioritise employee development, patient-centricity, and governance in global ESG strategies

10:00 am Roundtable Discussion: Enhancing Stakeholder Engagement: Social Strategies for Internal & External ESG Alignment

Synopsis

  • Exploring purpose lead leadership to immobilise stakeholders around a shared purpose
  • Successfully integrating ESG strategies within a company so that it is not just a tick box expertise
  • Deciphering best practises in setting goals that are inclusive, engaging, and useful

10:30 am Morning Break & Networking

Driving the Future of Sustainability: Exploring Impactful ESG Initiatives

11:30 am Choosing the Right ESG Initiatives: Prioritising Impact & Alignment

  • Chaojun Li Senior Director, Global Head of Sustainability, WS Audiology

Synopsis

  • Assessing the potential impact of ESG initiatives across key areas such as decarbonisation, resource optimisation, and water management
  • Developing a structured approach to prioritise initiatives that align with organisational goals and stakeholder expectations
  • Establishing measurable criteria to evaluate and implement ESG programs effectively

12:00 pm Aligning the Speak Up Hotline with ESRS Reporting Requirements

Synopsis

  • Exploring the Whistle-blower hotlines and their current focus 
  • Analysing the ESRS reporting requirements
  • Understanding corporate governance and roles and responsibility within an organisation, in relation to the speak up hotline 

12:30 pm Lunch & Networking

1:30 pm Achieving Supplier Diversity: Navigating Regional Challenges & Driving Meaningful Impact

  • Tom Wells Senior Director, Bristol Myers Squibb

Synopsis

  • Addressing regional complexities in supplier diversity, from U.S. requirements for minority and veteran-owned businesses to global variations in diversity definitions and reporting
  • Ensuring compliance with organisational requirements while fostering a meaningful and non-discriminatory approach to building a diverse supply chain
  • Communicating the significance of supplier diversity to procurement teams and stakeholders, highlighting tangible benefits, meaningful metrics and sharing practical global solutions

2:00 pm Roundtable Discussion: Optimising Lobbying Policies & Risk Assessment to Elevate Governance Practices

Synopsis

  • Defining risks and opportunities associated with anti-lobbying to enhance governance frameworks
  • Exploring best practices for collaborating with stakeholders to develop effective and transparent policies
  • Extrapolating actionable insights and key learnings to refine strategies and drive governance excellence

2:30 pm Above & Beyond – Ensuring Real-World Impact & Reporting on it With Patient

Synopsis

  • Understanding Patient engagement: Why it should be a strategic pillar for ESG reporting
  • Delving into ESG report analysis of pharma and medtech companies with regards to patient engagement
  • Exploring metrics to measure and report on patient engagement
  • Analysing implementation examples from life sciences and investors

2:30 pm Afternoon Break & Networking

3:00 pm Roundtable Discussion: Optimising Lobbying Policies & Risk Assessment to Elevate Governance Practices

Synopsis

  • Defining risks and opportunities associated with anti-lobbying to enhance governance frameworks
  • Exploring best practices for collaborating with stakeholders to develop effective and transparent policies.
  • Extrapolating actionable insights and key learnings to refine strategies and drive governance excellence

3:00 pm Chair’s Closing Remarks

3:05 pm End of Conference Day Two & the ESG in Life Science Summit Europe